Jardine Matheson Acquires Australias IMED Radiology in 24 Billion Healthcare Expansion Market Digest Allstate Electronic Arts Packaging Corp of America Sector Moves in Focus Stock Market Rally Continues Dow Jones Hits New High Nvidia Earnings Surge Crude Oil Fluctuates Pokmon Card Market Surges Nostalgia HighProfile Sales and Speculation Drive Collectible Frenzy Aequs Reports 33 Revenue Growth in FY26 But Losses Widen on Expansion Costs Singapore Inflation Slows More Than Expected in April Economic Growth Outlook Revised Upward HIND Q1 2026 Earnings EPS Beat Despite Limited Revenue Visibility ADAMN Q1 2026 Earnings Strong EPS Surprise of 75 Despite Modest Stock Pullback NBN Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline ALNT Q1 2026 Earnings EPS Falls Short of Estimates Stock Holds Steady RVLV Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Standard BioTools Q1 2026 Earnings Massive EPS Beat Fails to Lift Shares Amid Revenue Uncertainty Arbor Realty Trust ABR Slides 296 as Support Levels Come into Focus Sagimet Biosciences SGMT Inches Higher as Stock Tests Key Resistance at 748 Rezolute Inc RZLT Pushes Higher on Modest Volume as Traders Eye Biotech Catalysts Pimco New York Municipal Income Fund II PNI Edges Higher Amid Stable Trading Galectin Therapeutics Slips 3 as Stock Nears Key 257 Support Level Hanois Fine Dining Scene Highlights Key Restaurants Driving Culinary Growth SNY Q1 2026 Earnings EPS Beat on Strong Operational Execution Amid Broader Headwinds Warby Parker Stock Inches Up Navigating Support and Resistance for WRBY Upstream Bio Inc UPB Q1 2026 Earnings Narrowed Loss Per Share as Clinical Pipeline Advances ARE Q1 2026 Earnings Massive EPS Surprise Highlights Operational Strength BR Q1 2026 Earnings Solid Earnings Beat Driven by Operational Strength Volato Group Inc SOAR Q2 2025 Earnings Positive EPS Reported Amid Market Caution STLA Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally Ames National Corporation ATLO Q1 2026 Earnings Solid EPS Beat Amid Stable Operations Voyager Therapeutics Q1 2026 Earnings EPS Beats Estimates as Stock Rises Amid Pipeline Progress